AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Feb 5, 2015
30016_dirs_2015-02-05_d057e1aa-d3de-452b-adf7-ebd56cd920f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-03
Reporting Person: CRAIG THOMAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-03 | Common Stock | M | 1500 | $56.95 | Acquired | 13984 | Direct |
| 2015-02-03 | Common Stock | S | 1000 | $157.0490 | Disposed | 12984 | Direct |
| 2015-02-03 | Common Stock | S | 500 | $157.71 | Disposed | 12484 | Direct |
| 2015-02-04 | Common Stock | M | 700 | $56.95 | Acquired | 13184 | Direct |
| 2015-02-04 | Common Stock | S | 700 | $156.50 | Disposed | 12484 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-03 | Non-Qualified Stock Option | $56.95 | M | 1500 | Disposed | 2015-02-13 | Common Stock (1500) | Direct |
| 2015-02-04 | Non-Qualified Stock Option | $56.95 | M | 700 | Disposed | 2015-02-13 | Common Stock (700) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.50 to $157.40, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $157.52 to $157.91, inclusive.
F3: Grant of options to buy shares of common stock that vested on 02/14/2009.